Lakewood-Amedex Biotherapeutics Files S-1/A Amendment

Ticker: LABT · Form: S-1/A · Filed: 2026-04-06T11:38:04-04:00

Sentiment: neutral

Topics: securities-offering, registration-statement, amendment

TL;DR

Lakewood-Amedex Biotherapeutics filed an S-1/A amendment on 4/6/2026 for a securities registration.

AI Summary

Lakewood-Amedex Biotherapeutics Inc. filed an S-1/A amendment on April 6, 2026, to register securities. The filing includes various exhibits such as consents of independent registered public accounting firms and numerous graphic files, likely containing financial data and charts. The company is based in University Park, Florida.

Why It Matters

This S-1/A filing indicates Lakewood-Amedex Biotherapeutics is actively pursuing a securities offering, which could lead to new capital for the company's operations or expansion.

Risk Assessment

Risk Level: medium — S-1/A filings are typically associated with new securities offerings, which carry inherent risks related to market reception and company performance.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this S-1/A filing?

The S-1/A filing is an amendment to a registration statement for the registration of securities under the Securities Act of 1933.

When was this amendment filed?

This amendment was filed on April 6, 2026.

What is the company's CIK number?

The CIK number for Lakewood-Amedex Biotherapeutics Inc. is 0002079272.

Where is Lakewood-Amedex Biotherapeutics Inc. located?

The company's mailing and business address is 8031 Cooper Creek Blvd., Suite 103, University Park, FL 34201.

What types of exhibits are included in this filing?

The filing includes consents of independent registered public accounting firms and numerous graphic files (images and charts).

From the Filing

EDGAR Filing Documents for 0001213900-26-040254 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] SEC Accession No. 0001213900-26-040254 Filing Date 2026-04-06 Accepted 2026-04-06 11:38:04 Documents 18 Document Format Files Seq Description Document Type Size 1 REGISTRATION STATEMENT ea0248668-13.htm S-1/A 6903308 2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea024866813ex23-1.htm EX-23.1 1949 3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea024866813ex23-2.htm EX-23.2 1735 4 GRAPHIC timage_001.jpg GRAPHIC 559860 5 GRAPHIC tbarchart_001.jpg GRAPHIC 136287 6 GRAPHIC timage_002.jpg GRAPHIC 232945 7 GRAPHIC tlinechart_001.jpg GRAPHIC 358641 8 GRAPHIC timage_003.jpg GRAPHIC 355200 9 GRAPHIC timage_004.jpg GRAPHIC 386532 10 GRAPHIC timage_005.jpg GRAPHIC 435579 11 GRAPHIC tbarchart_002.jpg GRAPHIC 391982 12 GRAPHIC tbarchart_003.jpg GRAPHIC 415704 13 GRAPHIC tbarchart_004.jpg GRAPHIC 301195 14 GRAPHIC tbarchart_009.jpg GRAPHIC 315113 15 GRAPHIC tbarchart_005.jpg GRAPHIC 371265 16 GRAPHIC tbarchart_006.jpg GRAPHIC 258646 17 GRAPHIC tbarchart_007.jpg GRAPHIC 237466 18 GRAPHIC tbarchart_008.jpg GRAPHIC 272899 Complete submission text file 0001213900-26-040254.txt 13836562 Mailing Address 8031 COOPER CREEK BLVD. SUITE 103 UNIVERSITY PARK FL 34201 Business Address 8031 COOPER CREEK BLVD. SUITE 103 UNIVERSITY PARK FL 34201 9412252515 Lakewood-Amedex Biotherapeutics Inc. (Filer) CIK : 0002079272 (see all company filings) EIN. : 205274304 | State of Incorp.: NV | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

View on Read The Filing